Cargando…

Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis

Vaccination is one of the most effective measures for children as the epidemic progresses. However, there is a significant research gap in the meta-analysis of the COVID-19 vaccines for children younger than 18 years. This study is a comprehensive review of different COVID-19 vaccines. Published art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yan, Chen, Long, Shi, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864967/ https://www.ncbi.nlm.nih.gov/pubmed/36679932 http://dx.doi.org/10.3390/vaccines11010087

Ejemplares similares

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
por: Xia, ShengLi, et al.
Publicado: (2022)

Is the Marx Activity Scale Reliable in Patients Younger Than 18 Years?
por: Shirazi, Cameron P., et al.
Publicado: (2015)

Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
por: Gao, Peng, et al.
Publicado: (2023)

The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age
por: Yoshihara, Shigemi, et al.
Publicado: (2019)

Causes of death in children younger than five years in China in 2015: an updated analysis
por: Song, Peige, et al.
Publicado: (2016)

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis
por: Du, Yuxuan, et al.
Publicado: (2022)

A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years
por: Scala, Mario, et al.
Publicado: (2018)

COVID-19 vaccines for children younger than 12 years: are we ready?
por: Zou, Xiaohui, et al.
Publicado: (2021)

Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
por: Guo, Jianming, et al.
Publicado: (2023)

Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in Patients Younger than 18 Years
por: Lin, Chun-wang, et al.
Publicado: (2016)

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
por: Tang, Kuo-Tung, et al.
Publicado: (2022)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2020)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
por: Shi, Li-Wei, et al.
Publicado: (2023)

Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
por: Sharif, Nadim, et al.
Publicado: (2021)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

Adrenocortical tumors in children 18 years old and younger
por: Cho, Min Jeng, et al.
Publicado: (2012)

Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years
por: Troeger, Christopher, et al.
Publicado: (2018)

Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial
por: Zhu, Feng-Cai, et al.
Publicado: (2014)

Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial
por: Zhu, Feng‐cai, et al.
Publicado: (2016)

Cemented Polyethylene Cups in Patients Younger Than 40 Years
por: de Kam, Daniël C. J., et al.
Publicado: (2009)

Otitis media with effusion in children younger than 1 year
por: Di Francesco, Renata Cantisani, et al.
Publicado: (2016)

Clinical manifestations of headache in children younger than 7 years
por: Kang, Bu Seon, et al.
Publicado: (2018)

Osteoid Osteoma in Children Younger than 3 Years of Age
por: Laliotis, Nikolaos, et al.
Publicado: (2019)

Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: A clinical trial
por: Peyman, Alireza, et al.
Publicado: (2015)

Changes in conceptions in women younger than 18 years and the circumstances of young mothers in England in 2000–12: an observational study
por: Wellings, Kaye, et al.
Publicado: (2016)

Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years
por: Toepfner, Nicole, et al.
Publicado: (2022)

Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults
por: DiazGranados, Carlos A., et al.
Publicado: (2016)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine
por: Ghazy, Ramy Mohamed, et al.
Publicado: (2023)

Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea
por: Choi, Won Suk, et al.
Publicado: (2017)

1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
por: Gorse, Geoffrey J., et al.
Publicado: (2014)

Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
por: Muñoz, Flor M., et al.
Publicado: (2023)

A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
por: Ashmawy, Rasha, et al.
Publicado: (2022)

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
por: Schwarz, Tino F., et al.
Publicado: (2019)

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
por: Castellsagué, X, et al.
Publicado: (2011)

Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
por: Li, Zejun, et al.
Publicado: (2022)

Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS
por: Kalabus, J, et al.
Publicado: (2015)

Genetic background of ataxia in children younger than 5 years in Finland
por: Ignatius, Erika, et al.
Publicado: (2020)

Outcomes of Anterior Cruciate Ligament Reconstruction in Patients Older Than 50 Years and Younger Than 30 Years
por: Weng, Chun-Jui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hmf02j1unihnsb5cjasv72uouq